首页> 外文期刊>Innovations in Clinical Neuroscience >Augmentation of Venlafaxine with Aripiprazole in a Case of Treatment-resistant Excoriation Disorder
【24h】

Augmentation of Venlafaxine with Aripiprazole in a Case of Treatment-resistant Excoriation Disorder

机译:难治性心脏衰竭患者加用阿立哌唑增强文拉法辛

获取原文
       

摘要

We present a case of a 21-year-old woman with excoriation disorder that was resistant to currently reported treatment options. Severe lesions were present on multiple sites of her body. The skin picking appeared to be associated with anxiety surrounding her current medical stay and medical condition. The addition of aripiprazole to the venlafaxine she was already taking resulted in resolution of her unconscious picking. This medication combination may be considered by clinicians in the future for treatment-resistant excoriation disorder as its side effect profile is favorable for patients who have failed first-line treatment options. Large-scale studies investigating the use of second generation antipsychotics combined with selective serotonin reuptake inhibitors/serotonin norepinephrine reuptake inhibitors for the treatment of excoriation disorder is recommended.
机译:我们介绍了一名21岁女性患有勒索症的患者,该患者对目前报道的治疗选择有抵抗力。她身体的多个部位都存在严重的病变。皮肤选择似乎与她目前的医疗住宿和医疗状况有关。她已经服用的文拉法辛中添加了阿立哌唑,这使她无意识的采摘得以解决。将来,这种药物组合可能会被临床医生考虑用于治疗性顽固性敲除障碍,因为它的副作用对一线治疗选择失败的患者有利。建议进行大规模研究,研究第二代抗精神病药与选择性5-羟色胺再摄取抑制剂/ 5-羟色胺去甲肾上腺素再摄取抑制剂联合用于治疗排精障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号